Lilly

Stock market information for Lilly(Eli) & Co (LLY): Lilly(Eli) & Co is an equity in the USA market. The price is 779.28 USD currently with a change of 3.20 USD (0.00%) from the previous close. The latest trade time is Thursday, July 3, 04:14:55 PDT.

Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana.

Established in 1876 by Colonel Eli Lilly, a pharmaceutical chemist and Union army veteran, the company has a rich history of innovation and commitment to improving global health.

Company Overview

Over the years, Lilly has developed a diverse portfolio of medications across various therapeutic areas, including oncology, immunology, neuroscience, and diabetes.

Notable products include Trulicity, Mounjaro, Verzenio, Taltz, Jardiance, Humalog, Cyramza, Olumiant, Emgality, Tyvyt, Retevmo, Alimta, and Zepbound.

Recent Developments

In recent years, Lilly has made significant strides in the treatment of obesity and diabetes. The company introduced tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, which gained FDA approval in November 2023.

These medications have shown promising results in clinical trials, leading to substantial growth in Lilly's valuation.

Global Presence

Lilly's global presence is extensive, with operations in 18 countries and products sold in approximately 125 countries. The company employs over 47,000 individuals worldwide, with a significant portion dedicated to research and development.

Locations

• Indianapolis, IN, USA - Headquarters and main operations center
• Durham, NC, USA - Regional office focusing on research and development
• Bayonne, NJ, USA - Additional office location supporting multiple business functions

Philanthropy and Research

In addition to its pharmaceutical endeavors, Lilly has a history of philanthropic initiatives, including the production of penicillin and other antibiotics during World War II.

The company continues to invest heavily in research and development to address unmet medical needs and improve patient outcomes globally.

Industry Position

Lilly's commitment to innovation and patient care has solidified its position as a leader in the pharmaceutical industry, with a focus on delivering high-quality medications to improve lives worldwide.